198 related articles for article (PubMed ID: 32738045)
1. Landscape of DNA binding signatures of myocyte enhancer factor-2B reveals a unique interplay of base and shape readout.
Dantas Machado AC; Cooper BH; Lei X; Di Felice R; Chen L; Rohs R
Nucleic Acids Res; 2020 Sep; 48(15):8529-8544. PubMed ID: 32738045
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structure of Apo MEF2B Reveals New Insights in DNA Binding and Cofactor Interaction.
Lei X; Shi H; Kou Y; Rajashekar N; Wu F; Sen C; Xu J; Chen L
Biochemistry; 2018 Jul; 57(28):4047-4051. PubMed ID: 29944822
[TBL] [Abstract][Full Text] [Related]
3. Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2.
Han A; Pan F; Stroud JC; Youn HD; Liu JO; Chen L
Nature; 2003 Apr; 422(6933):730-4. PubMed ID: 12700764
[TBL] [Abstract][Full Text] [Related]
4. Mouse Mef2b gene: unique member of MEF2 gene family.
Morisaki T; Sermsuvitayawong K; Byun SH; Matsuda Y; Hidaka K; Morisaki H; Mukai T
J Biochem; 1997 Nov; 122(5):939-46. PubMed ID: 9443808
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2.
Han A; He J; Wu Y; Liu JO; Chen L
J Mol Biol; 2005 Jan; 345(1):91-102. PubMed ID: 15567413
[TBL] [Abstract][Full Text] [Related]
6. In Silico Exploration of Conformational Dynamics and Novel Inhibitors for Targeting MEF2-Associated Transcriptional Activity.
Zia A; Imran M; Rashid S
J Chem Inf Model; 2020 Mar; 60(3):1892-1909. PubMed ID: 32031799
[TBL] [Abstract][Full Text] [Related]
7. Systematic transition modeling analysis in the MEF2B-DNA binding interface due to Y69H and K4E variants.
Zia A; Rashid S
J Mol Graph Model; 2021 Nov; 108():108009. PubMed ID: 34418874
[TBL] [Abstract][Full Text] [Related]
8. Structure of the MADS-box/MEF2 domain of MEF2A bound to DNA and its implication for myocardin recruitment.
Wu Y; Dey R; Han A; Jayathilaka N; Philips M; Ye J; Chen L
J Mol Biol; 2010 Mar; 397(2):520-33. PubMed ID: 20132824
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
Moore EM; Swerdlow SH; Gibson SE
Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
[TBL] [Abstract][Full Text] [Related]
10. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
11. The floral homeotic protein SEPALLATA3 recognizes target DNA sequences by shape readout involving a conserved arginine residue in the MADS-domain.
Käppel S; Melzer R; Rümpler F; Gafert C; Theißen G
Plant J; 2018 Jul; 95(2):341-357. PubMed ID: 29744943
[TBL] [Abstract][Full Text] [Related]
12. Bispecific Forkhead Transcription Factor FoxN3 Recognizes Two Distinct Motifs with Different DNA Shapes.
Rogers JM; Waters CT; Seegar TCM; Jarrett SM; Hallworth AN; Blacklow SC; Bulyk ML
Mol Cell; 2019 Apr; 74(2):245-253.e6. PubMed ID: 30826165
[TBL] [Abstract][Full Text] [Related]
13. MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation.
Pon JR; Wong J; Saberi S; Alder O; Moksa M; Grace Cheng SW; Morin GB; Hoodless PA; Hirst M; Marra MA
Nat Commun; 2015 Aug; 6():7953. PubMed ID: 26245647
[TBL] [Abstract][Full Text] [Related]
14. Vertebrate paralogous MEF2 genes: origin, conservation, and evolution.
Wu W; de Folter S; Shen X; Zhang W; Tao S
PLoS One; 2011 Mar; 6(3):e17334. PubMed ID: 21394201
[TBL] [Abstract][Full Text] [Related]
15. [Expression of myocyte enhancer factor 2B in mantle cell lymphoma and its clinical significance].
Liu F; Liu Q; Guo N; Zhang GM; Deng YF; Hu WW; Rao HL
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):40-46. PubMed ID: 31914533
[No Abstract] [Full Text] [Related]
16. Mutations within the conserved MADS box of the D-MEF2 muscle differentiation factor result in a loss of DNA binding ability and lethality in Drosophila.
Nguyen T; Wang J; Schulz RA
Differentiation; 2002 Oct; 70(8):438-46. PubMed ID: 12366381
[TBL] [Abstract][Full Text] [Related]
17. Big mitogen-activated kinase regulates multiple members of the MEF2 protein family.
Kato Y; Zhao M; Morikawa A; Sugiyama T; Chakravortty D; Koide N; Yoshida T; Tapping RI; Yang Y; Yokochi T; Lee JD
J Biol Chem; 2000 Jun; 275(24):18534-40. PubMed ID: 10849446
[TBL] [Abstract][Full Text] [Related]
18. The MEF2B homologue differentially expressed in mouse embryonal carcinoma cells.
Hidaka K; Morisaki T; Byun SH; Hashido K; Toyama K; Mukai T
Biochem Biophys Res Commun; 1995 Aug; 213(2):555-60. PubMed ID: 7646512
[TBL] [Abstract][Full Text] [Related]
19. MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis.
Brescia P; Schneider C; Holmes AB; Shen Q; Hussein S; Pasqualucci L; Basso K; Dalla-Favera R
Cancer Cell; 2018 Sep; 34(3):453-465.e9. PubMed ID: 30205047
[TBL] [Abstract][Full Text] [Related]
20. Quantitative modeling of transcription factor binding specificities using DNA shape.
Zhou T; Shen N; Yang L; Abe N; Horton J; Mann RS; Bussemaker HJ; Gordân R; Rohs R
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4654-9. PubMed ID: 25775564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
